Agena Bioscience

Targeted molecular analysis system utilizing MALDI-TOF mass spectrometry with a 96-well configuration for genetic research applications.

MassARRAY System configured with a Chip Prep Module and 96-well format for targeted genetic analysis.

Catalog item 10447 for MassARRAY System with Chip Prep Module for high-throughput 384 Genotyping.

A benchtop multiplex genetic analyzer designed to simplify the complex clinical genetics environment with easy-to-interpret data, flexible biomarker detection, and robust performance.

Catalog item 10446 for MassARRAY System with Chip Prep Module configured for EpiTyper applications.

Catalog item 10448 for MassARRAY System with Chip Prep Module configured for 384 EpiTyper applications.

Designed to enable study of disease progression and treatment monitoring from circulating tumor cells and ctDNA, detecting over 90 variants across five genes associated with CRC.

Assay-specific primers and required reagents for processing plasma DNA samples on the MassARRAY System.

Liquid biopsy panel for the detection of EGFR variants in cfDNA samples, ideally suited for research studies in non-small cell lung cancer.

An ultrasensitive MALDI-TOF-based mutation panel comprised of 26 hotspot mutations across 12 oncogenes for low abundance mutation detection.

Enables research studies from CTCs and ctDNA across 61 variants, detected at as low as 0.1% variant allele frequency (VAF).

A liquid biopsy panel for the detection of variants in colorectal cfDNA samples, enabling studies on colorectal research samples using as little as 10 ng of cfDNA.

An advanced pharmacogenetic analysis panel with updated gene targets aligned with AMP Tier 1 and Tier 2 recommendations for standardized pharmacogenomic testing.

VeriDose Core v2.0 panel set configured for 10x96 chip format, supporting 320 samples.

A pharmacogenomics genotyping panel designed to encompass all AMP Tier 1 and Tier 2 DPYD variants, along with four additional markers of emerging population and functional relevance.

A single-well multiplex panel of 18 DPYD gene targets designed to be compliant with the AMP-led joint consensus recommendations testing for Tier 1 and Tier 2 DPYD pan-ethnic variants, plus four additional variants.

VeriDose DPYD Panel Set in 10x96 reaction format for 960 samples, supporting varying sample throughput for pharmacogenetic research.

Expanded CFTR variant coverage aligned with updated recommendations from leading societies for hereditary genetic analysis.

CFTR 100+ Panel Set packaged for 10x384 chip format.

CFTR 100+ assay set configured for 384 CPM format supporting 640 samples.

Enables multiplexed variant detection in lung cancer research, identifying 70 variants across key genes at allele frequencies as low as 1%.

iPLEX Pro SampleID Panel Set formatted for 3840 samples using 384 CPM plates.

Facilitates variant detection of over 100 variants at as low as 1% VAF from poor quality and degraded samples such as FFPE tissue and cytology blocks.

Detects over 100 variants at as low as 1% VAF from poor quality and degraded samples such as FFPE tissue, smears, fine needle aspirates and core needle biopsies.

Molecular identity tracking with 44 SNPs, optimized for use with exome analysis.

Determines a sample's identity, DNA quality, and DNA quantity, and screens for sample degradation by providing the number of intact, amplifiable DNA copies across multiple fragment lengths.

Optimized for use with exome analysis, the iPLEX Pro Exome QC Panel targets exonic regions to provide rapid and accurate sample identification for 3840 samples using a 384 CPM format.

Targeted detection of common and rare variants associated with hereditary hemochromatosis.

Comprehensive 6-variant HFE research panel set supporting 3,840 samples in a 384 CPM format.

An automated targeted genetic analysis system offering load-and-go processing, automated post-PCR sample handling, and remote analysis for up to 960 samples per day.

A pre-validated multiplex genotyping panel covering more than 230 somatic mutations across 19 common oncogenes for the MassARRAY System.

A reverse transcription PCR and MALDI-TOF test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in upper respiratory specimens and bronchoalveolar lavage.

Flexible assay development to support laboratory-specific hereditary genetics targets.

Proprietary chemistry optimized for precise variant discrimination in a scalable format on the MassARRAY System.

A predesigned panel for analyzing critical hot-spot mutations in solid tumors and circulating plasma DNA with a sensitivity of ≤ 10% mutation frequency.

Assay-specific primers and required reagents for processing tissue DNA samples on the MassARRAY System.

Software tool for designing custom panels on the MassARRAY System, integrating all assay design steps into a single software package.

Targets the most relevant variants in 16 key genes implicated in drug metabolism pathways, providing genotype information for 85 SNPs/INDELs recommended by leading societies.

Multiplexing chemistry that allows the detection of over 100 variants, including insertions and deletions, using cfDNA from a single blood draw.

DNA bisulfite treatment kit in a 96-well plate format for 192 samples.

DNA bisulfite treatment kit in a tube format for 50 samples.